879 related articles for article (PubMed ID: 24584119)
1. Multiplexed ion beam imaging of human breast tumors.
Angelo M; Bendall SC; Finck R; Hale MB; Hitzman C; Borowsky AD; Levenson RM; Lowe JB; Liu SD; Zhao S; Natkunam Y; Nolan GP
Nat Med; 2014 Apr; 20(4):436-42. PubMed ID: 24584119
[TBL] [Abstract][Full Text] [Related]
2. Imaging: Lighting up tumours.
Villanueva MT
Nat Rev Clin Oncol; 2014 May; 11(5):240. PubMed ID: 24663125
[No Abstract] [Full Text] [Related]
3. Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging.
Levenson RM; Borowsky AD; Angelo M
Lab Invest; 2015 Apr; 95(4):397-405. PubMed ID: 25730370
[TBL] [Abstract][Full Text] [Related]
4. Receptor conversion in distant breast cancer metastases.
Hoefnagel LD; van de Vijver MJ; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van der Groep P; de Vries EG; van der Wall E; van Diest PJ
Breast Cancer Res; 2010; 12(5):R75. PubMed ID: 20863372
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed ion beam imaging analysis for quantitation of protein expression in cancer tissue sections.
Rost S; Giltnane J; Bordeaux JM; Hitzman C; Koeppen H; Liu SD
Lab Invest; 2017 Aug; 97(8):992-1003. PubMed ID: 28553935
[TBL] [Abstract][Full Text] [Related]
6. Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.
Berg D; Langer R; Tran K; Walch A; Schuster T; Bronger H; Becker KF
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):300-5. PubMed ID: 21293257
[TBL] [Abstract][Full Text] [Related]
7. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
[TBL] [Abstract][Full Text] [Related]
8. Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
Caselli E; Pelliccia C; Teti V; Bellezza G; Mandarano M; Ferri I; Hartmann K; Laible M; Sahin U; Varga Z; Lupi C; Stracci F; Sidoni A
PLoS One; 2021; 16(9):e0255580. PubMed ID: 34555047
[TBL] [Abstract][Full Text] [Related]
9. Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
Wilson TR; Xiao Y; Spoerke JM; Fridlyand J; Koeppen H; Fuentes E; Huw LY; Abbas I; Gower A; Schleifman EB; Desai R; Fu L; Sumiyoshi T; O'Shaughnessy JA; Hampton GM; Lackner MR
Breast Cancer Res Treat; 2014 Nov; 148(2):315-25. PubMed ID: 25338319
[TBL] [Abstract][Full Text] [Related]
10. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.
Gerdes MJ; Sevinsky CJ; Sood A; Adak S; Bello MO; Bordwell A; Can A; Corwin A; Dinn S; Filkins RJ; Hollman D; Kamath V; Kaanumalle S; Kenny K; Larsen M; Lazare M; Li Q; Lowes C; McCulloch CC; McDonough E; Montalto MC; Pang Z; Rittscher J; Santamaria-Pang A; Sarachan BD; Seel ML; Seppo A; Shaikh K; Sui Y; Zhang J; Ginty F
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11982-7. PubMed ID: 23818604
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
Eppenberger-Castori S; Kueng W; Benz C; Caduff R; Varga Z; Bannwart F; Fink D; Dieterich H; Hohl M; Müller H; Paris K; Schoumacher F; Eppenberger U
J Clin Oncol; 2001 Feb; 19(3):645-56. PubMed ID: 11157014
[TBL] [Abstract][Full Text] [Related]
12. Analytical and clinical performance of progesterone receptor antibodies in breast cancer.
Calhoun BC; Mosteller B; Warren D; Smith M; Jordi Rowe J; Lanigan CP; Mrazeck KC; Walker E; Newell AH; Jones R
Ann Diagn Pathol; 2018 Aug; 35():21-26. PubMed ID: 29758480
[TBL] [Abstract][Full Text] [Related]
13. A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.
Jensen K; Krusenstjerna-Hafstrøm R; Lohse J; Petersen KH; Derand H
Mod Pathol; 2017 Feb; 30(2):180-193. PubMed ID: 27767098
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor expression in breast cancer associates with older patient age.
Belova L; Delgado B; Kocherginsky M; Melhem A; Olopade OI; Conzen SD
Breast Cancer Res Treat; 2009 Aug; 116(3):441-7. PubMed ID: 18668364
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients.
Dodson A; Parry S; Ibrahim M; Bartlett JM; Pinder S; Dowsett M; Miller K
J Pathol Clin Res; 2018 Oct; 4(4):262-273. PubMed ID: 30066480
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
20. Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype.
Zanardi E; Di Meglio A; Boccardo C; Zinoli L; Salvi S; Rubagotti A
Oncol Res Treat; 2020; 43(7-8):362-371. PubMed ID: 32512573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
